Eliciting HIV-1 Specific T Cells from Healthy Individuals
Author Information
Author(s): Reche Pedro A, Keskin Derin B, Hussey Rebecca E, Ancuta Petronela, Gabuzda Dana, Reinherz Ellis L
Primary Institution: Dana-Farber Cancer Institute
Hypothesis
Can cytotoxic T lymphocytes (CTL) be effectively elicited from virus-naive individuals against conserved HIV-1 epitopes?
Conclusion
Virus-naive individuals can generate strong CTL responses against conserved HIV-1 epitopes, unlike a minority of HIV-1 infected individuals.
Supporting Evidence
- Healthy individuals can expand T cells that produce IFNγ in response to HIV-1 peptides.
- Only a minority of HIV-1 infected individuals respond to the same peptide pools.
- The study suggests a shift in vaccine design focus from infected to healthy individuals.
Takeaway
This study shows that healthy people can create strong defenses against HIV, while many people already infected with the virus struggle to do so.
Methodology
The study involved generating T cell lines from healthy donors and testing their responses to HIV-1 peptide pools using ELISPOT assays.
Potential Biases
Potential bias in the selection of epitopes and the population studied.
Limitations
The study primarily focused on a limited number of epitopes and may not represent the full range of immune responses.
Participant Demographics
Participants included 47 HIV-1 infected patients with varying HLA backgrounds.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website